Dev Drugs (India) Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 1996.
1996 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Dev Drugs (India) Private Limited

Dev Drugs (India) Private Limited, a active private limited company, was established on 23 October 1996 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U65929DL1996PTC082829. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.60 M.

Formerly known as Noni Gopal Infinlease Private Limited. It upholds a compliant status. Employing 7 professional, Its leadership includes Subrata Roy (Director), Balbir Singh (Director). Past directors included Mitali Roy, Subrata Roy, Rabindra Kumar Bishwas. It holds ₹8.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at D-67 Pandav Nagar, Patparganj, New Delhi, Delhi, 110092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U65929DL1996PTC082829

  • Registration Number

    082829

  • Incorporation Date

    23 October 1996

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹1.60 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 1.60 M
  • Company Age 29 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 8.50 Cr
  • Revenue Growth **** -43.04%
  • Profit Growth **** -185.76%
  • Ebitda **** 122.72%
  • Net Worth -17.50%
  • Total Assets -4.55%
Company report

Dev Drugs (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dev Drugs (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Dev Drugs (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Subrata Roy Director 14 Sep 2021 Current
Balbir Singh Director 15 Sep 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 14 Sep 2021 Past
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Director 08 Apr 2021 Past
Pramod Abcsdd Director 15 Sep 2020 Past
Pramod Abcsdd Additional Director 31 Dec 2020 Past
Pramod Abcsdd Director 16 Sep 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dev Drugs (India).

Dev Drugs (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 43.04% decrease. The company also saw a substantial fall in profitability, with a 185.76% decrease in profit. The company's net worth observed a substantial decline by a decrease of 17.5%.

Dev Drugs (India) revenue growth over time
Dev Drugs (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -43.04%
*******
*******
*******
*******
Revenue from Operations
*******
 -18.12%
*******
*******
*******
*******
Total Assets
*******
 -4.55%
*******
*******
*******
*******
Profit or Loss
*******
 -185.76%
*******
*******
*******
*******
Net Worth
*******
 -17.50%
*******
*******
*******
*******
EBITDA
*******
 122.72%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dev Drugs (India)?

In 2023, Dev Drugs (India) had a public holding of 6.24%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹85,028,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Sidbi : 8.50 Cr
Latest Charge Details
Date Lender Amount Status
22 May 2025 Sidbi ₹2.55 Cr Open
29 Mar 2023 Sidbi ₹2.65 Cr Open
30 Mar 2022 Sidbi ₹2.00 Cr Open
03 Nov 2020 Sidbi ₹1.30 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Dev Drugs (India)?

Dev Drugs (India) has a workforce of 7 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dev Drugs (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dev Drugs (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dev Drugs (India)
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Dev Drugs (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    The activity A charge with Sidbi amounted to Rs. 25.50 M with Charge ID 101100671 was registered on 22 May 2025. was completed.

  • Balance Sheet

    Dev Drugs (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Charges

    The activity A charge with Sidbi amounted to Rs. 26.50 M with Charge ID 100703582 was registered on 29 Mar 2023. was completed.

  • Charges

    The activity A charge with Sidbi of Rs. 13.03 M registered on 03 Nov 2020 with Charge ID 100382532 was modified on 25 Mar 2023. was completed.

  • Charges

    Progress on A charge with Sidbi amounted to Rs. 20.00 M with Charge ID 100552164 was registered on 30 Mar 2022. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dev Drugs (India) Private Limited?

The CIN of Dev Drugs (India) Private Limited is U65929DL1996PTC082829.

Where is Dev Drugs (India) Private Limited headquartered?

Dev Drugs (India) Private Limited is headquartered at D-67 Pandav Nagar, Patparganj, New Delhi, Delhi, 110092.

When was Dev Drugs (India) Private Limited incorporated?

Dev Drugs (India) Private Limited was incorporated on 23 October 1996.

Who are the current directors of Dev Drugs (India) Private Limited?

The current directors of Dev Drugs (India) Private Limited are

What is the primary industry of Dev Drugs (India) Private Limited?

The primary industry of Dev Drugs (India) Private Limited is Manufacturing.

Is Dev Drugs (India) Private Limited a listed company?

Dev Drugs (India) Private Limited is unlisted.

What is the capital structure of Dev Drugs (India) Private Limited?

The authorized capital of Dev Drugs (India) Private Limited is ₹2.50 M, and the paid-up capital is ₹1.60 M.

What is the compliance status of Dev Drugs (India) Private Limited?

The compliance status of Dev Drugs (India) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available